Hull Hans (CIK 0001614876)

Latest company ownership

ADVM - Adverum Biotechnologies, Inc.
Role: SVP, Business Operations
Shares held
137,210
Last filed at
Aug 25, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
PLRX - PLIANT THERAPEUTICS, INC.
Role: Chief Business Officer
Shares held
31,791
Last filed at
Jul 12, 2024
Confidence Score
49.8
2025Q4
Confidence Score History
2022Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 17, 2025 Jan 22, 2025 PLIANT THERAPEUTICS, INC. Chief Business Officer Sell 32.5 -15,936 -6.15% ✓ $178.5K
Jul 10, 2024 Jul 12, 2024 PLIANT THERAPEUTICS, INC. Chief Business Officer Sell 37.5 -9,900 -3.68% ✓ $114.4K
Jan 17, 2024 Jan 19, 2024 PLIANT THERAPEUTICS, INC. Chief Business Officer Sell 37.5 -9,786 -4.32% ✓ $168.6K
Aug 3, 2023 Aug 7, 2023 PLIANT THERAPEUTICS, INC. Chief Business Officer Sell 35.0 -31,319 -4.67% ✓ $626.6K
Jul 17, 2023 Jul 19, 2023 PLIANT THERAPEUTICS, INC. Chief Business Officer Sell 30.0 -17,937 -6.67% ✓ $323K
Mar 30, 2023 Apr 3, 2023 PLIANT THERAPEUTICS, INC. Chief Business Officer Sell 37.5 -9,036 -3.72% ✓ $239.6K
Dec 19, 2022 Dec 21, 2022 PLIANT THERAPEUTICS, INC. Chief Business Officer Sell 90.0 +8,830 5.48% ✗ $167.1K
Jun 4, 2015 Jun 5, 2015 Adverum Biotechnologies, Inc. SVP, Business Operations Sell 20.0 -2,000 -15.02% ✓ $75.3K
May 4, 2015 May 6, 2015 Adverum Biotechnologies, Inc. SVP, Business Operations Sell 10.0 -5,000 -30.64% ✓ $154.3K
Apr 7, 2015 Apr 8, 2015 Adverum Biotechnologies, Inc. SVP, Business Operations Sell 5.0 -27,500 -89.23% ✓ $1.1M